The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.
Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.
Weinstein Receives Award; LRFA Honors Vincent Devita.
New Office For Protection Of Research Subjects Formed.
Marijuana Ingredient Promotes Tumor Growth, Study Finds.
Cvitkovic Responds To Story On March ODAC Meeting.
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions









